Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2020 | CD19 CAR-T for lymphoma: real-world experience in the UK

Andrea Kuhnl • 14 Jun 2020
EHA 2020
Lymphoma CAR-T
JULIET ZUMA-1

Andrea Kuhnl, MD, King’s College Hospital, London, United Kingdom, updates us on real-world experience in the UK of high-grade lymphoma patients treated with CD19 CAR T-cell therapy. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Andrea Kuhnl

4:11
Evaluating radiotherapy bridging in patients with LBCL receiving CD19 CAR-T therapy
Andrea Kuhnl • 14 Jun 2023
10:22
CD19 CAR-T in lymphoma patients in the UK
Andrea Kuhnl • 23 May 2020
3:09
UK CAR-T: changing the landscape of lymphoma treatment
Andrea Kuhnl • 15 Jun 2020

Related Videos

1:32
Promising novel immunotherapeutic approaches in lymphoma
Gloria Iacoboni • 15 Apr 2024
3:03
AlloSCT outcomes after immunotherapy vs chemotherapy in patients with R/R NHL: a retrospective study
Jacopo Mariotti • 15 Apr 2024
2:28
Checkpoint inhibitors vs brentuximab vedotin as salvage therapy prior to alloSCT for HL
Jacopo Mariotti • 15 Apr 2024
1:37
Exciting CAR-T clinical trials in LBCL and FL
Gloria Iacoboni • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals